Why the study?
Does the use of bromocriptine and anticoagulation therapy improve outcomes and counteract fibrosis in peripartum cardiomyopathy patients?
Does the use of bromocriptine and anticoagulation therapy improve outcomes and counteract fibrosis in peripartum cardiomyopathy patients?
Answers are grounded in this paper and cite their sources.
Differences in medical therapy, specifically bromocriptine and anticoagulation, may explain the better outcomes and less profibrotic biomarker profiles seen in German versus South African peripartum cardiomyopathy patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Azibani et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: